Wyeth Keeps Producing
37904
The drug maker's difficulties are evident, but its productivity may make it worth a second look.
234771
1U rocket ship IDF Floating point whiz ClearSpeed continues to round out its software play ahead of several major product upgrades.â¦
652959
The movies' love affair with W. Somerset Maugham is still going strong.
240983
Wyeth  on Thursday said its  second-quarter earnings rose on higher sales of its  prescription drugs.
761165
Wyeth (nyse: WYE - news - people ) is set to begin the second phase of a Philadelphia trial in which a plaintiff alleges heart valve injury from the use of the diet drug Pondimin, a drug the company once marketed.
640367
Israel's Teva Pharmaceutical  Industries Ltd   raised its 2007 earnings  outlook following the launch of its generic version of Wyeth's   ulcer drug Protonix.
188330
Pharmaceutical firm Wyeth said Tuesday that the Food and Drug Administration granted fast-track status to its experimental cancer drug temsirolimus as an initial treatment for patients with advanced kidney ...
761698
Treatment with Wyeth's drug temsirolimus, which secured U.S. regulatory approval on Wednesday, extended survival for 3 1/2 months for patients with advanced renal-cell carcinoma, according to a company-sponsored study.
642953
One new stock has left quite a footprint.
44172
Biotech giant Inc. Amgen and the pharmaceuticals division of health-care products company Wyeth said Tuesday the Food and Drug Administration approved their arthritis treatment Enbrel to induce a major clinical
335428
Wyeth WYE.N on Monday reported a  fourth-quarter loss despite strong sales growth of its  prescription medicines, as it took another charge of $4.5  billion for costs related to its recalled fen-phen diet drugs.
425484
Wyeth  said on Monday that it received a second approvable letter from U.S regulators for bazedoxifene, a drug that helps prevent bone deterioration in post-menopausal women.
199021
The women's clothing and accessories retailer continues to produce impressive results.
559190
Wyeth on Monday reported a quarterly  loss due to a $4.5 billion charge for its recalled "fen-phen"  diet drugs and warned of disappointing profit for 2005, sending  its shares down almost 8 percent.
176
Wyeth  on Thursday raised its 2006 profit forecast and said its recently approved Tygacil antibiotic and three experimental medicines all could post annual sales in the billions of dollars.
351819
Drugmaker Wyeth WYE.N has reached a  tentative framework with a group of plaintiffs' lawyers to  settle nearly all remaining liability cases stemming from  allegations that some of its diet drugs damaged heart valves,  the Wall Street Journal reported on Tuesday, citing people  familiar with the negotiations.
362336
By Thomas Ginsberg, The Philadelphia Inquirer  Dec. 19--Wyeth Pharmaceuticals said today that the FDA has agreed to conduct a fast-track review of the company's new kidney cancer-fighting drug, Torisel.